Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

CRMD – CorMedix Inc.

CorMedix Inc.
CRMD
$11.63
Name : CorMedix Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $788,801,344.00
EPSttm : 0.25
finviz dynamic chart for CRMD
CorMedix Inc.
$11.63
1.94%
$0.23

Float Short %

12.97

Margin Of Safety %

Put/Call OI Ratio

0.35

EPS Next Q Diff

-0.12

EPS Last/This Y

1.1

EPS This/Next Y

0.71

Price

11.63

Target Price

16.83

Analyst Recom

1

Performance Q

15.72

Relative Volume

0.58

Beta

1.6

Ticker: CRMD




22 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-04-14CRMD7.140.421.3244716
2025-04-15CRMD7.410.430.3444993
2025-04-16CRMD7.510.430.2245853
2025-04-17CRMD7.660.390.4753931
2025-04-18CRMD7.670.390.4753931
2025-04-21CRMD8.140.530.2239021
2025-04-22CRMD8.480.520.0840064
2025-04-23CRMD8.440.470.1543905
2025-04-24CRMD9.140.470.1344122
2025-04-25CRMD9.10.453653564375360.04383975812547245636
2025-04-28CRMD9.060.444985029940120.9835680751173746332
2025-04-29CRMD9.110.440.1146408
2025-04-30CRMD9.180.430.1346880
2025-05-01CRMD9.640.420.2347545
2025-05-02CRMD9.390.420.0848463
2025-05-05CRMD9.010.410.1548771
2025-05-06CRMD11.150.400.2451525
2025-05-07CRMD11.660.380.1352830
2025-05-08CRMD12.020.380.0352796
2025-05-09CRMD11.70.360.0455275
2025-05-12CRMD11.860.350.1356993
2025-05-13CRMD11.630.350.0157586
DateSymbolLastP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-04-14CRMD7.13198.0- 0.68
2025-04-15CRMD7.40198.0- 0.68
2025-04-16CRMD7.52198.0- 0.68
2025-04-17CRMD7.67198.0- 0.68
2025-04-18CRMD7.67198.0- 0.68
2025-04-21CRMD8.14198.0- 0.68
2025-04-22CRMD8.50198.0- 0.68
2025-04-23CRMD8.45198.0- 0.68
2025-04-24CRMD9.13198.0- 0.68
2025-04-25CRMD9.10198.0- 0.68
2025-04-28CRMD9.06198.0- 0.68
2025-04-29CRMD9.12198.0- 0.68
2025-04-30CRMD9.18198.0- 0.68
2025-05-01CRMD9.65198.0- 0.68
2025-05-02CRMD9.38198.0- 0.68
2025-05-05CRMD9.03198.0- 0.68
2025-05-06CRMD11.14198.0- 0.68
2025-05-07CRMD11.68198.0- 0.68
2025-05-08CRMD12.03198.0- 0.68
2025-05-09CRMD11.64198.0- 0.80
2025-05-12CRMD11.86198.0- 0.80
2025-05-13CRMD11.63149.3- 0.80
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-04-14CRMD-2.4121.4413.30
2025-04-15CRMD-2.4121.4413.30
2025-04-16CRMD-2.4121.4413.30
2025-04-17CRMD-2.4121.4413.30
2025-04-18CRMD-2.4121.4413.30
2025-04-21CRMD-2.4121.1813.30
2025-04-22CRMD-2.4121.1813.30
2025-04-23CRMD-2.4121.1813.30
2025-04-24CRMD-2.4121.1813.30
2025-04-25CRMD-2.4121.1813.30
2025-04-28CRMD-2.4121.1613.85
2025-04-29CRMD-2.4121.1613.85
2025-04-30CRMD-2.4121.1613.85
2025-05-01CRMD-2.4121.1613.85
2025-05-02CRMD-2.4121.1613.85
2025-05-05CRMD-2.4119.0713.85
2025-05-06CRMD-2.4119.0713.85
2025-05-07CRMD-2.4119.0713.85
2025-05-08CRMD-2.3219.0713.85
2025-05-09CRMD-2.3219.0713.32
2025-05-12CRMD-2.3212.2812.97
2025-05-13CRMD-2.3212.2812.97
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

0.3

Avg. EPS Est. Current Quarter

0.12

Avg. EPS Est. Next Quarter

0.18

Insider Transactions

-2.32

Institutional Transactions

12.28

Beta

1.6

Average Sales Estimate Current Quarter

29

Average Sales Estimate Next Quarter

35

Fair Value

Quality Score

99

Growth Score

42

Sentiment Score

85

Actual DrawDown %

38.1

Max Drawdown 5-Year %

-84.5

Target Price

16.83

P/E

51.6

Forward P/E

7.71

PEG

P/S

9.56

P/B

6.85

P/Free Cash Flow

EPS

0.23

Average EPS Est. Cur. Y​

0.8

EPS Next Y. (Est.)

1.51

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

20.81

Relative Volume

0.58

Return on Equity vs Sector %

-8.7

Return on Equity vs Industry %

8.2

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.25

EBIT Estimation

CorMedix Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 64
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
stock quote shares CRMD – CorMedix Inc. Stock Price stock today
news today CRMD – CorMedix Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch CRMD – CorMedix Inc. yahoo finance google finance
stock history CRMD – CorMedix Inc. invest stock market
stock prices CRMD premarket after hours
ticker CRMD fair value insiders trading